Healthcare Analytics, Population Health Management, Healthcare Big Data

Genetic Testing

23andMe, Lark Health Join Genetics, AI, Diabetes Prevention

January 9, 2019 - Consumer genetic test company 23andMe has announced a partnership with Lark Health, provider of AI-driven health coaching programs, to allow consumers to use genetic test results to inform their approach to wellness. The collaboration will integrate the results of 23andMe genetic tests into Lark Health’s wellness programming and CDC-recognized Diabetes Prevention Program...

More Articles

Effective Precision Medicine Requires Moving Beyond the EHR

by Jennifer Bresnick

Electronic health records are not enough to support truly effective precision medicine at the point of care, said providers participating in a survey from KLAS research, but more targeted health IT tools are producing high rates of...

FDA Clears 23andMe Genetic Test for Medication Metabolism Variants

by Jennifer Bresnick

Consumers will now be able to purchase an over-the-counter test to screen for genetic variants that may influence medication metabolism, the FDA has announced. The direct-to-consumer test from 23andMe is a first for the American market,...

Consumers Curious About AI, Genetic Testing for Precision Medicine

by Jennifer Bresnick

Healthcare consumers are cautious but optimistic that emerging strategies like artificial intelligence and advanced genetic testing can lead to better care for cancer, according to a new survey from McKesson and Ipsos. The poll of more...

Machine Learning, Genomics Predict Risk of Aortic Aneurysm

by Jennifer Bresnick

The combination of machine learning tools and genomic data can help predict the risk of abdominal aortic aneurysm (AAA), one of the most frequently fatal heart conditions - and one that is most often diagnosed only after a patient’s...

Precision Medicine Researchers Identify New Alzheimer’s Genes

by Jessica Kent

Researchers from Boston University School of Medicine, in collaboration with scientists from the Alzheimer’s Disease Sequencing Project (ADSP), have discovered new genes that could contribute to the onset of Alzheimer’s...

Boston Children’s to Sequence DNA of 3000 Chronic Disease Patients

by Jessica Kent

Boston Children’s Hospital has announced that it will offer complete DNA sequencing to 3000 patients with epilepsy and inflammatory bowel disease in an effort to target treatments and accelerate medical research. The initiative will...

How to Bring Precision Medicine into Routine Clinical Care

by Jessica Kent

Precision medicine has taken the healthcare industry by storm in recent years, offering the promise of more individualized treatments, improved patient outcomes, and a deeper understanding of genetic conditions and rare...

Alabama Recruits for Statewide Population Health, Genomics Program

by Jessica Kent

The Alabama Genomic Health Initiative (AGHI) has begun recruiting participants for its population health program that will use genomic analysis to predict disease. AGHI is a collaborative effort between the University of Alabama at...

NCI Studies Link Dozens of Genetic Variants to Cancer

by Jessica Kent

The discovery of genetic variants that are associated with cancer development could assist providers with identifying high-risk patients and crafting precision medicine therapies for oncology, according to new research funded by the...

WVU Genetic Test to Improve Lung Cancer Treatment

by Jessica Kent

Researchers at the West Virginia University (WVU) Cancer Institute are developing a genetic test that will improve treatment for patients with lung cancer and help physicians determine which patients will benefit from chemotherapy and...

Broader Availability of Genetic Testing a Boon for Precision Care

by Jennifer Bresnick

Precision medicine is quickly moving out of the realm of science fiction and into the everyday routines of oncologists, neurologists, and other providers treating patients who may have had little hope just a few short years ago. While the...

NIH Grants $10M to Newborn Genome Sequencing Project

by Jessica Kent

The National Institutes of Health (NIH) has awarded a $10 million, four-year grant to HudsonAlpha Institute of Biotechnology in support of their newborn whole genome sequencing project, which will help with the diagnosis and care of...

Intermountain Launches Prospective Precision Medicine Study

by Jennifer Bresnick

Intermountain Healthcare is launching a new precision medicine project that will allow researchers to take a prospective view on the potential of genomic data. The PRECISE study allows for the collection of fresh-frozen tissue and blood...


Join 25,000 of your peers

Register for free to get access to all our articles, webcasts, white papers and exclusive interviews.

Our privacy policy

no, thanks

Continue to site...